Bright Peak Therapeutics AG

AI Quick Summary

Bright Peak Therapeutics AG is a pioneering Basel and San Diego-based biotech using a blend of chemical synthesis, protein engineering and recombinant technology to create and develop multifunctional immunotherapies for cancer and autoimmune diseases. Our flexible technology platform allows us to conjugate enhanced cytokine “payloads” to existing antibodies and generate what we call “Bright Peak Immunoconjugates”. The company was spun out from the ETH Zürich in 2017 and is expecting to initiate clinical trials for BPT567 – a PD1-IL18 conjugate for cancer immunotherapy.

Organization Metadata

• Organization Name: Bright Peak Therapeutics AG
• Date: 9/19/2024 2:44:42 PM
• Administrators:
  • Park Basel Area  | 
  • Jeremy Beauchamp

Organization Description

Bright Peak Therapeutics AG is a pioneering Basel and San Diego-based biotech using a blend of chemical synthesis, protein engineering and recombinant technology to create and develop multifunctional immunotherapies for cancer and autoimmune diseases. Our flexible technology platform allows us to conjugate enhanced cytokine “payloads” to existing antibodies and generate what we call “Bright Peak Immunoconjugates”. The company was spun out from the ETH Zürich in 2017 and is expecting to initiate clinical trials for BPT567 – a PD1-IL18 conjugate for cancer immunotherapy.